How Much Does a GLP-1 Actually Cost Without Insurance? (The Honest Number)

The short answer, before you scroll

Paying cash, the honest range for a compounded GLP-1 right now runs roughly **$130 to $250 a month for semaglutide** and **$200 to $350 for tirzepatide**, depending on the provider and your dose. Brand-name pens (Wegovy, Zepbound, Ozempic) with no coverage sit far above that — often **$1,000+ a month** at list price. The cheapest *verified* sticker on our shortlist is a compounded semaglutide program near $129/mo; the cheapest *honest* one — flat price, both molecules, no month-two surprise — is a little higher but doesn't detonate later. I break down why below, because the lowest number on the ad is almost never the number you actually carry.

The usual boundary, kept honest: I walk the public signup funnels and write down the prices I can see without creating an account or entering medical info — this is observed pricing plus general education, not medical advice. The clinical claims below are checked against published trials and FDA-cleared labeling.

Why "cheapest" is only half the number

Every GLP-1 ad leads with a jaw-dropping intro price. The asterisk is doing the heavy lifting. The three traps I see over and over:

The headline is usually a **first-month or introductory rate** tied to the lowest starter dose or a prepaid multi-month bundle — it can jump at month two once "new patient" pricing lapses. **Dose matters to your bill**: titration steps you up over weeks, and on some pricing models a higher dose means a higher monthly charge, so the sticker that assumes you'll sit at the starter dose forever is quietly optimistic. And the quote may be for **compounded** medication, not the brand pen — a completely different price story I get into below. So the real question isn't "what's the intro price," it's "what will month three and month six cost, at the dose I'll actually be on."

The real monthly range, provider by provider

Here's the cash landscape as it stands on our shortlist, so you can anchor to real numbers instead of ad copy. The budget end is a compounded-semaglutide program at about **$129/mo** — the lowest verified monthly sticker I walked, with the price shown early (here's that review). A GLP-1-only specialist sits close behind near **$139/mo for semaglutide and $229 for tirzepatide** (the focused pick). The pick I'd point a friend to first, CoreAge Rx, runs a **flat $149/mo for semaglutide and $349 for tirzepatide** — not the rock-bottom sticker, but the price on screen is the price you pay, both molecules live on one account, and nothing steps up in the fine print. More hand-holding programs run higher, around **$239/mo**, for more clinician oversight and follow-up.

Then there's the insurance-and-brand lane — the WeightWatchers- and Noom-style programs that aim at FDA-approved brand medication and work your coverage. Those can be cheaper *if* insurance plays along, but the cash number is a mystery until you're through the quiz, so budget for uncertainty there. I ranked the whole field by real cost on the cheapest GLP-1 board, and I logged the gap between the ad and my actual card in what I paid vs. what I expected.

Compounded vs. brand: the single biggest price lever

This is where the thousand-dollar gap lives. Most of the shockingly low monthly numbers are for **compounded** semaglutide or tirzepatide — a pharmacy-prepared version — not the brand-name pens. It's a real category with real savings, but it's a different product story: formulation, availability, and oversight can differ, and pricing shifts with supply. Brand pens deliver the exact molecules studied in the big trials — once-weekly semaglutide drove about 15% average body-weight loss in adults with overweight or obesity¹, and tirzepatide reached roughly 15-21% depending on dose² — but at cash list price they're an order of magnitude more expensive than compounded. The budgeting takeaway isn't "avoid brand" or "avoid compounded" — it's *know which one you're being quoted*, because comparing a compounded monthly price against a brand price is apples to oranges. Ask, on the intake, exactly what medication the number covers.

The other line items: membership, orals, and dose step-ups

A few things quietly inflate the "monthly" number. Some platforms layer a **membership or program fee** on top of the medication, so the true cost is medication plus subscription. **Oral GLP-1s** exist but the cash math often isn't cheaper than an injection at the same provider. And as noted, **dose step-ups** can raise the bill on models that price by dose. When you compare, line up the *all-in* monthly cost at your likely maintenance dose — medication, fees, and shipping — not the starter-dose teaser.

The cost nobody budgets for: staying on it

Here's the line item that blindsides people, and it reframes the whole math. GLP-1 medicines manage weight *while you take them* — they aren't a one-and-done course. In the STEP 1 trial extension, people who stopped semaglutide regained a large share of the lost weight over the following year³. The controlled STEP 4 trial showed people who switched to placebo regained while those who continued kept losing⁴. Tirzepatide's SURMOUNT-4 told the same story — stopping led to substantial regain, continuing maintained the loss⁵.

Why does that belong in a cost article? Because the price that actually matters is the *sustainable* monthly one you can carry for a year-plus — not the thrilling intro rate you'll resent by spring. A flat $149 you can hold beats a $79 teaser that becomes $220 at month two and that you quietly quit by summer.

So what's the genuinely cheapest honest option?

If the monthly number is your entire decision, the budget compounders near $129-$139/mo are the lowest verified stickers, and I'd send you to the cheapest GLP-1 board to compare them head to head. If you want *cheap you can plan around* — a flat price shown before you hand over your medical history, both molecules, no month-two detonation — that's why CoreAge Rx sits at the top of our list, and you can even finish the async intake without a video visit while the baby naps.

And the standing truth: this is educational, not medical advice, and GLP-1 medicines are not for use in pregnancy or while trying to conceive. What's right — and affordable — for your family is a conversation for you and your own clinician.